CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma.
Cheng SL, Wu CH, Tsai YJ, Song JS, Chen HM, Yeh TK, Shen CT, Chiang JC, Lee HM, Huang KW, Chen Y, Qiu JT, Yen YT, Shia KS, Chen Y.
Cheng SL, et al. Among authors: lee hm.
J Control Release. 2025 Jan 31;379:967-981. doi: 10.1016/j.jconrel.2025.01.066. Online ahead of print.
J Control Release. 2025.
PMID: 39863023